Subscribe free

Newsletter

HPB & Spleen

Every new paper in this field, in your inbox.

FreeNo spamOne-click unsubscribe
Surg Endosc1 May 2024

Significant Variability in Managing Malignant Gastric Outlet Obstruction in Pancreatic Cancer, with Rising Use of EUS-Gastrojejunostomy

Survey of 290 pancreatologists revealed significant differences in managing malignant gastric outlet obstruction (MGOO) due to pancreatic cancer. Endoscopic stenting (ES) was most common, but EUS-Gastrojejunostomy (EUS-GJ) adoption is increasing. Decision drivers include life expectancy and patient frailty, with lack of standardized algorithms. Availability of…

HPB & Spleen1 May 2024

Nomogram Predicts Survival in Lymph Node-Negative Hepatocellular Carcinoma

Clinicians developed a nomogram to predict cancer-specific survival (CSS) in hepatocellular carcinoma (HCC) patients without lymph node metastasis (LNM), achieving high accuracy in both internal and external validation. Analysis of 6,840 HCC patients revealed age, gender, bone metastasis, lung metastasis, AFP, T stage, surgery, and…

HPB & Spleen30 Apr 2024

Malpractice Claims Following Major Liver and Pancreatic Surgeries

General surgery is a highly litigious specialty, with most claims related to delays in diagnosis or surgical negligence. A study analyzing malpractice cases from the last two decades found that the majority named surgeons as defendants, with a higher likelihood of verdicts favoring defendants. Payouts…

HPB & Spleen29 Apr 2024

Hidden Port Site Incision for Robotic Foregut and Hepatopancreatobiliary Operation

Developed to minimize visible scars on the abdomen, the hidden port site incision technique at the pubic hairline offers a cosmetically superior approach for common foregut and hepatopancreatobiliary procedures. This technique maximizes cosmetic outcomes while maintaining clinical efficacy, especially beneficial for patients with poor healing…